Patents by Inventor Cyril Montagne

Cyril Montagne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200077648
    Abstract: The present invention relates to compounds of the formula (I), in particular to phenoxyphenylamidines of the formula (I), to a process for their preparation, to the use of phenoxyphenylamidines of the formula (I) according to the invention for controlling unwanted microorganisms, in particular phytopathogenic fungi and also to a composition for this purpose, comprising the phenoxyphenylamidines of the formula (I) according to the invention. Furthermore, the invention relates to a method for controlling unwanted microorganisms, in particular phytopathogenic fungi, characterized in that the compounds of the formula (I) are applied to the microorganisms, in particular to the phytopathogenic fungi and/or in their habitat.
    Type: Application
    Filed: December 13, 2017
    Publication date: March 12, 2020
    Applicants: Bayer CropScience Aktiengesellschaft, Bayer Aktiengesellschaft
    Inventors: Cyril MONTAGNE, Stefan HILLEBRAND, Mazen ES-SAYED, Andreas GÖRTZ, Ulrike WACHENDORFF-NEUMANN, Thomas SEITZ, Jörg GREUL, Sergii PAZENOK, Klaus KUNZ
  • Publication number: 20190313638
    Abstract: The invention relates to active compound combinations, in particular within a composition, which comprises (A) one or more phenylamidine compounds of formula (I) and one or more fungicidal compounds (B). Moreover, the invention relates to a method for controlling the phytopathogenic fungi of plants, to the use of an active compound combination according to the invention for the treatment of one or more seeds, to a method for protecting one or more seeds and to the corresponding treated seed.
    Type: Application
    Filed: December 13, 2017
    Publication date: October 17, 2019
    Inventors: Cyril MONTAGNE, Stefan HILLEBRAND, Mazen ES-SAYED, Andreas GOERTZ, Ulrike WACHENDORFF-NEUMANN
  • Publication number: 20190308933
    Abstract: The present invention relates to compounds of the formula (I), in particular to phenylamidines of the formula (I), to a process for their preparation, to the use of phenylamidines of the formula (I) according to the invention for controlling unwanted microorganisms, in particular phytopathogenic fungi and also to a composition for this purpose, comprising the phenylamidines of the formula (I) according to the invention. Furthermore, the invention relates to a method for controlling unwanted microorganisms, in particular phytopathogenic fungi, characterized in that the compounds of the formula (I) are applied to the microorganisms, in particular to the phytopathogenic fungi and/or in their habitat.
    Type: Application
    Filed: December 13, 2017
    Publication date: October 10, 2019
    Applicants: Bayer CropScience Aktiengesellschaft, Bayer Aktiengesellschaft
    Inventors: Cyril MONTAGNE, Mazen ES-SAYED, Andreas GÖRTZ, Ulrike WACHENDORFF-NEUMANN
  • Patent number: 10349656
    Abstract: The present invention relates to novel difluoromethyl-nicotinic indanyl carboxamides, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically active compounds, especially for control of harmful microorganisms in crop protection and in the protection of materials.
    Type: Grant
    Filed: June 22, 2015
    Date of Patent: July 16, 2019
    Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    Inventors: Christophe Dubost, Philipp Winter, Marco Brünjes, Mark James Ford, Ulrike Wachendorff-Neumann, Cyril Montagne, Jean-Pierre Vors, Stephane Brunet, Philippe Rinolfi
  • Patent number: 10039283
    Abstract: The present invention relates to novel substituted pyrazolyl-nicotin(thio)amide derivatives, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically active compounds, especially for control of harmful microorganisms, in crop protection and in the protection of materials.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: August 7, 2018
    Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    Inventors: Christophe Dubost, Cyril Montagne, Ulrike Wachendorff-Neumann, Phillipp Winter, Strphane Brunet, Jean-Pierre Vors, Pierre-Yves Coqueron, Joerg Greul
  • Publication number: 20180057462
    Abstract: The present invention relates to novel substituted 2-difluoromethyl-nicotin(thio)carboxanilides derivatives, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically active compounds, especially for control of harmful microorganisms in crop protection and in the protection of materials.
    Type: Application
    Filed: February 15, 2016
    Publication date: March 1, 2018
    Inventors: CHRISTOPHE DUBOST, SIMON MAECHLING, II, PHILIPP WINTER, ULRIKE WACHENDORFF-NEUMANN, CYRIL MONTAGNE, JEAN-PIERRE VORS, STEPHANE BRUNET
  • Patent number: 9878985
    Abstract: The present invention relates to novel benzocyclobutane(thio) carboxamides, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically active compounds, especially for control of harmful microorganisms in crop protection and in the protection of materials.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: January 30, 2018
    Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    Inventors: Christophe Dubost, Ulrike Wachendorff-Neumann, Philipp Winter, Stephane Brunet, Jean-Pierre Vors, Cyril Montagne
  • Publication number: 20170150717
    Abstract: The present invention relates to novel difluoromethyl-nicotinic indanyl carboxamides, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically active compounds, especially for control of harmful microorganisms in crop protection and in the protection of materials.
    Type: Application
    Filed: June 22, 2015
    Publication date: June 1, 2017
    Inventors: Christophe DUBOST, Philipp WINTER, Marco BRÜNJES, Mark James FORD, Ulrike WACHENDORFF-NEUMANN, Cyril MONTAGNE, Jean-Pierre VORS, Stephane BRUNET, Philippe RINOLFI
  • Publication number: 20170142969
    Abstract: The present invention relates to novel substituted pyrazolyl-nicotin(thio)amide derivatives, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically active compounds, especially for control of harmful microorganisms, in crop protection and in the protection of materials.
    Type: Application
    Filed: March 31, 2015
    Publication date: May 25, 2017
    Inventors: CHRISTOPHE DUBOST, CYRIL MONTAGNE, ULRIKE WACHENDORFF-NEUMANN, PHILIPP WINTER, STEPHANE BRUNET, JEAN-PIERRE VORS, PIERRE-YVES COQUERON, JOERG GREUL
  • Publication number: 20160264529
    Abstract: The present invention relates to novel benzocyclobutane(thio) carboxamides, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically active compounds, especially for control of harmful microorganisms in crop protection and in the protection of materials.
    Type: Application
    Filed: October 28, 2014
    Publication date: September 15, 2016
    Inventors: Christophe DUBOST, Ulrike WACHENDORFF-NEUMANN, Philipp WINTER, Stephane BRUNET, Jean-Pierre VORS, Cyril MONTAGNE
  • Patent number: 9403835
    Abstract: The present invention provides compounds of Formula (I) as M1 receptor positive allosteric modulators for the treatment of diseases mediated by the muscarinic M1 mediator.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: August 2, 2016
    Assignee: Ares Trading S.A.
    Inventors: Dominique Swinnen, Cyril Montagne, Vincent Pomel, Anna Quattropani, Jerome Molette, Patrick Gerber
  • Publication number: 20150274657
    Abstract: The invention relates to compounds of formula I: wherein: R is H or alkyl, X denotes one of the following groups: Y is OH, Oalkyl, NR2R3. The compounds are useful e.g. in the treatment of autoimmune and/or inflammatory disorders, such as multiple sclerosis.
    Type: Application
    Filed: September 10, 2013
    Publication date: October 1, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Cyril Montagne, Jerome Molette, Julie Routier
  • Publication number: 20150018343
    Abstract: The present invention provides compounds of Formula (I) as M1 receptor positive allosteric modulators for the treatment of diseases mediated by the muscarinic M1 mediator.
    Type: Application
    Filed: November 30, 2012
    Publication date: January 15, 2015
    Inventors: Dominique Swinnen, Cyril Montagne, Vincent Pomel, Anna Quattropani, Jerome Molette, Patrick Gerber
  • Patent number: 8889668
    Abstract: The invention relates to compounds of formula (I): wherein R1, R2, Ra, Rb, Rc and W, have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.
    Type: Grant
    Filed: December 12, 2012
    Date of Patent: November 18, 2014
    Assignee: Merck Serono SA
    Inventors: Cyril Montagne, Anna Quattropani, Wolfgang Sauer, Agnes Bombrun
  • Patent number: 8815919
    Abstract: The invention relates to oxadiazole compounds of formula I. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: August 26, 2014
    Assignee: Merck Serono SA
    Inventors: Anna Quattropani, Cyril Montagne, Wolfgang Sauer, Stefano Crosignani, Agnès Bombrun
  • Patent number: 8802704
    Abstract: The invention relates to oxadiazole compounds of formula I. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: August 12, 2014
    Assignee: Merck Serono SA
    Inventors: Anna Quattropani, Cyril Montagne, Wolfgang Sauer, Stefano Crosignani, Agnès Bombrun
  • Patent number: 8741923
    Abstract: The invention provides compounds of Formula (I) for the treatment of multiple sclerosis and other diseases.
    Type: Grant
    Filed: December 15, 2009
    Date of Patent: June 3, 2014
    Assignee: Merck Serono SA
    Inventors: Mathilde Muzerelle, Anna Quattropani, Cyril Montagne, Jérôme Dorbais
  • Patent number: 8614215
    Abstract: The present invention is related to quinoxaline compounds of Formula (I) in particular for the treatment of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
    Type: Grant
    Filed: February 21, 2008
    Date of Patent: December 24, 2013
    Assignee: Merck Serono SA
    Inventors: Pascale Gaillard, Vincent Pomel, Isabelle Jeanclaude-Etter, Jerome Dorbais, Jasna Klicic, Cyril Montagne
  • Patent number: 8609666
    Abstract: This invention relates to compounds of Formula (I) as Pi3k inhibitors for treating autoimmune diseases, inflammatory disorders, multiple sclerosis and other diseases like cancers.
    Type: Grant
    Filed: February 4, 2010
    Date of Patent: December 17, 2013
    Assignee: Merck Serono SA
    Inventors: Cyril Montagne, Agnés Bombrun, Gwenaelle Desforges-Bouscary, Anna Quattropani, Pascale Gaillard
  • Patent number: 8404676
    Abstract: The invention relates to compounds of formula (I): wherein R1, R2, Ra, Rb, Rc and W, have the meanings given in claim 16. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.
    Type: Grant
    Filed: October 1, 2008
    Date of Patent: March 26, 2013
    Assignee: Merck Serono SA
    Inventors: Cyril Montagne, Anna Quattropani, Wolfgang Sauer, Agnes Bombrun